111 related articles for article (PubMed ID: 26791841)
1. Neoadjuvant Treatment for Surgically Resectable Metastatic Colorectal Cancer: Is There an Optimal Succession?
Patel K; Sun W
Oncology (Williston Park); 2016 Jan; 30(1):23, 27-8. PubMed ID: 26791841
[No Abstract] [Full Text] [Related]
2. Neoadjuvant Treatment for Surgically Resectable Metastatic Colorectal Cancer.
Al-Hajeili M; Marshall JL; Smaglo BG
Oncology (Williston Park); 2016 Jan; 30(1):10-6. PubMed ID: 26791840
[TBL] [Abstract][Full Text] [Related]
3. Metastatic colorectal cancer: is surgery necessary?
Schmidt C
J Natl Cancer Inst; 2009 Aug; 101(16):1113-5. PubMed ID: 19671774
[No Abstract] [Full Text] [Related]
4. [Neoadjuvant chemotherapy with capecitabine plus oxaliplatin and bevacizumab for the treatment of patients with resectable metastatic colorectal cancer].
Kemmochi T; Egawa T; Mihara K; Ito Y; Ohkubo Y; Mori T; Nagashima A; Makino H; Yamamuro W
Gan To Kagaku Ryoho; 2013 Nov; 40(12):1629-31. PubMed ID: 24393871
[TBL] [Abstract][Full Text] [Related]
5. Treating rectal cancer: key issues reconsidered.
Fakih M
Oncology (Williston Park); 2008 Nov; 22(12):1444-6. PubMed ID: 19322952
[No Abstract] [Full Text] [Related]
6. [What are the roles of neoadjuvant, adjuvant and palliative chemotherapy in the management of hepatic metastasis of colorectal origin?].
Guimbaud R;
Gastroenterol Clin Biol; 2003 Mar; 27 Spec No 2():B14-5, B63-79. PubMed ID: 12637873
[No Abstract] [Full Text] [Related]
7. Thirty years of rectal cancer research: a brief history.
Czito BG; Willett CG
Oncology (Williston Park); 2008 Nov; 22(12):1441-2, 1444. PubMed ID: 19322951
[No Abstract] [Full Text] [Related]
8. Does neoadjuvant chemotherapy reveal disease precluding surgical treatment of initially resectable colorectal cancer liver metastases?
Reddy SK; Tsung A; Marsh JW; Geller DA
J Surg Oncol; 2012 Jan; 105(1):55-9. PubMed ID: 21842519
[TBL] [Abstract][Full Text] [Related]
9. Timing of adjuvant and neoadjuvant therapy in colorectal cancers.
Bayraktar S; Bayraktar UD; Rocha-Lima CM
Clin Colorectal Cancer; 2010 Jul; 9(3):144-9. PubMed ID: 20643618
[TBL] [Abstract][Full Text] [Related]
10. Colorectal cancer metastases: surgical indications and multimodal approach.
Ciferri E; Bondanza GS; Municinò O; Castagnola M; Gazzaniga GM
Hepatogastroenterology; 2003; 50(54):1836-46. PubMed ID: 14696416
[TBL] [Abstract][Full Text] [Related]
11. Adjuvant Therapy After Resection of Metastatic Colorectal Cancer: Scant Evidence of a Curative Benefit.
Marshall JL
Oncology (Williston Park); 2016 Jan; 30(1):50, 52-3. PubMed ID: 26791845
[No Abstract] [Full Text] [Related]
12. Adjuvant Therapy After Resection of Metastatic Colorectal Cancer: Clear Proof of Principle in This Setting.
Coutinho A; Grothey A
Oncology (Williston Park); 2016 Jan; 30(1):50-1, 53. PubMed ID: 26791844
[No Abstract] [Full Text] [Related]
13. [Neoadjuvant chemotherapy for advanced colorectal cancer].
Ohira G; Miyauchi H; Suzuki K; Nishimori T; Tohma T; Narushima K; Matsubara H
Gan To Kagaku Ryoho; 2013 Nov; 40(12):1626-8. PubMed ID: 24393870
[TBL] [Abstract][Full Text] [Related]
14. Neoadjuvant chemotherapy for non-/resectable metastases.
Folprecht G
Eur J Cancer; 2011 Sep; 47 Suppl 3():S52-60. PubMed ID: 21944029
[No Abstract] [Full Text] [Related]
15. How shall we name the chemotherapy administration before and after metastasectomy? How about "M-neoadjuvant" and "M-adjuvant"?
Abali H; Dişel U; Urün Y; Güllü I; Saif MW
Ann Surg Oncol; 2010 Jul; 17(7):1970. PubMed ID: 20217255
[No Abstract] [Full Text] [Related]
16. Neoadjuvant and adjuvant therapy in relation to surgery for colorectal liver metastases.
Brouquet A; Nordlinger B
Scand J Gastroenterol; 2012 Mar; 47(3):286-95. PubMed ID: 22182353
[TBL] [Abstract][Full Text] [Related]
17. Neoadjuvant and adjuvant chemotherapy in muscle-invasive bladder cancer.
Calabrò F; Sternberg CN
Eur Urol; 2009 Feb; 55(2):348-58. PubMed ID: 18977070
[TBL] [Abstract][Full Text] [Related]
18. Neoadjuvant chemotherapy for locally advanced breast cancer results in alterations in preoperative tumor marker status.
Cahill RA; Watson RG
Am Surg; 2008 Mar; 74(3):271-2. PubMed ID: 18376698
[No Abstract] [Full Text] [Related]
19. Role of diffusion-weighted imaging as an adjunct to contrast-enhanced breast MRI in evaluating residual breast cancer following neoadjuvant chemotherapy.
Hahn SY; Ko EY; Han BK; Shin JH; Ko ES
Eur J Radiol; 2014 Feb; 83(2):283-8. PubMed ID: 24315957
[TBL] [Abstract][Full Text] [Related]
20. [Present status of clinical trials of neoadjuvant chemotherapy for gastric cancer and key points in their design].
Zhang XT
Zhonghua Zhong Liu Za Zhi; 2013 Aug; 35(8):636-8. PubMed ID: 24314226
[No Abstract] [Full Text] [Related]
[Next] [New Search]
